Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are twenty patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first on DrugPatentWatch - Make Better Decisions.